Hye-Youn Cho1, Daniel L Morgan, Alison K Bauer, Steven R Kleeberger. 1. Laboratory of Respiratory Biology, National Institute of Environmental Health Sciences, National Institutes of Health, 111 TW Alexander Drive, Building 101, MD D-201, Research Triangle Park, NC 27709, USA. cho2@niehs.nih.gov
Abstract
RATIONALE: Increasing evidence suggests that tumor necrosis factor (TNF)-alpha plays a key role in pulmonary injury caused by environmental ozone (O(3)) in animal models and human subjects. We previously determined that mice genetically deficient in TNF response are protected from lung inflammation and epithelial injury after O(3) exposure. OBJECTIVES: The present study was designed to determine the molecular mechanisms of TNF receptor (TNF-R)-mediated lung injury induced by O(3). METHODS: TNF-R knockout (Tnfr(-/-)) and wild-type (Tnfr(+/+)) mice were exposed to 0.3 ppm O(3) or air (for 6, 24, or 48 h), and lung RNA and proteins were prepared. Mice deficient in p50 nuclear factor (NF)-kappaB (Nfkb1(-/-)) or c-Jun-NH(2) terminal kinase 1 (Jnk1(-/-)) and wild-type controls (Nfkb1(+/+), Jnk1(+/+)) were exposed to O(3) (48 h), and the role of NF-kappaB and mitogen-activated protein kinase (MAPK) as downstream effectors of lung injury was analyzed by bronchoalveolar lavage analyses. RESULTS: O(3)-induced early activation of TNF-R adaptor complex formation was attenuated in Tnfr(-/-) mice compared with Tnfr(+/+) mice. O(3) significantly activated lung NF-kappaB in Tnfr(+/+) mice before the development of lung injury. Basal and O(3)-induced NF-kappaB activity was suppressed in Tnfr(-/-) mice. Compared with Tnfr(+/+) mice, MAPKs and activator protein (AP)-1 were lower in Tnfr(-/-) mice basally and after O(3). Furthermore, inflammatory cytokines, including macrophage inflammatory protein-2, were differentially expressed in Tnfr(-/-) and Tnfr(+/+) mice after O(3). O(3)-induced lung injury was significantly reduced in Nfkb1(-/-) and Jnk1(-/-) mice relative to respective control animals. CONCLUSIONS: Results suggest that NF-kappaB and MAPK/AP-1 signaling pathways are essential in TNF-R-mediated pulmonary toxicity induced by O(3).
RATIONALE: Increasing evidence suggests that tumor necrosis factor (TNF)-alpha plays a key role in pulmonary injury caused by environmental ozone (O(3)) in animal models and human subjects. We previously determined that mice genetically deficient in TNF response are protected from lung inflammation and epithelial injury after O(3) exposure. OBJECTIVES: The present study was designed to determine the molecular mechanisms of TNF receptor (TNF-R)-mediated lung injury induced by O(3). METHODS:TNF-R knockout (Tnfr(-/-)) and wild-type (Tnfr(+/+)) mice were exposed to 0.3 ppm O(3) or air (for 6, 24, or 48 h), and lung RNA and proteins were prepared. Mice deficient in p50 nuclear factor (NF)-kappaB (Nfkb1(-/-)) or c-Jun-NH(2) terminal kinase 1 (Jnk1(-/-)) and wild-type controls (Nfkb1(+/+), Jnk1(+/+)) were exposed to O(3) (48 h), and the role of NF-kappaB and mitogen-activated protein kinase (MAPK) as downstream effectors of lung injury was analyzed by bronchoalveolar lavage analyses. RESULTS:O(3)-induced early activation of TNF-R adaptor complex formation was attenuated in Tnfr(-/-) mice compared with Tnfr(+/+) mice. O(3) significantly activated lung NF-kappaB in Tnfr(+/+) mice before the development of lung injury. Basal and O(3)-induced NF-kappaB activity was suppressed in Tnfr(-/-) mice. Compared with Tnfr(+/+) mice, MAPKs and activator protein (AP)-1 were lower in Tnfr(-/-) mice basally and after O(3). Furthermore, inflammatory cytokines, including macrophage inflammatory protein-2, were differentially expressed in Tnfr(-/-) and Tnfr(+/+) mice after O(3). O(3)-induced lung injury was significantly reduced in Nfkb1(-/-) and Jnk1(-/-) mice relative to respective control animals. CONCLUSIONS: Results suggest that NF-kappaB and MAPK/AP-1 signaling pathways are essential in TNF-R-mediated pulmonary toxicity induced by O(3).
Authors: P E Tolbert; J A Mulholland; D L MacIntosh; F Xu; D Daniels; O J Devine; B P Carlin; M Klein; J Dorley; A J Butler; D F Nordenberg; H Frumkin; P B Ryan; M C White Journal: Am J Epidemiol Date: 2000-04-15 Impact factor: 4.897
Authors: C E Donovan; D A Mark; H Z He; H C Liou; L Kobzik; Y Wang; G T De Sanctis; D L Perkins; P W Finn Journal: J Immunol Date: 1999-12-15 Impact factor: 5.422
Authors: Stephanie A Shore; Erin S Williams; Lucas Chen; Leandro A P Benedito; David I Kasahara; Ming Zhu Journal: Inhal Toxicol Date: 2011-11-08 Impact factor: 2.724
Authors: Jonathan M Ciencewicki; Kirsten C Verhein; Kevin Gerrish; Zachary R McCaw; Jianying Li; Pierre R Bushel; Steven R Kleeberger Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-04-22 Impact factor: 5.464
Authors: Hye-Youn Cho; Anne E Jedlicka; Wesley Gladwell; Jacqui Marzec; Zackary R McCaw; Rachelle J Bienstock; Steven R Kleeberger Journal: Antioxid Redox Signal Date: 2014-11-12 Impact factor: 8.401
Authors: Mary Francis; Angela M Groves; Richard Sun; Jessica A Cervelli; Hyejeong Choi; Jeffrey D Laskin; Debra L Laskin Journal: Toxicol Sci Date: 2016-11-11 Impact factor: 4.849
Authors: Stavros Garantziotis; Zhuowei Li; Erin N Potts; James Y Lindsey; Vandy P Stober; Vasiliy V Polosukhin; Timothy S Blackwell; David A Schwartz; W Michael Foster; John W Hollingsworth Journal: Am J Respir Crit Care Med Date: 2009-12-10 Impact factor: 21.405
Authors: Gautam Damera; Hengjiang Zhao; Miao Wang; Michael Smith; Christopher Kirby; William F Jester; John A Lawson; Reynold A Panettieri Journal: Am J Physiol Lung Cell Mol Physiol Date: 2009-02-06 Impact factor: 5.464